Supplemental material: histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors

Supplemental tables/figures for the publication in JAAD, "Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors". Accepted for publication 10/2021.

本补充表格与附图为发表于《美国皮肤病学会杂志》（Journal of the American Academy of Dermatology，简称JAAD）的论文《皮肤免疫相关不良事件（cutaneous immune-related adverse events）的组织学亚型可预测接受免疫检查点抑制剂（immune checkpoint inhibitors）治疗患者的总生存期（overall survival）》的配套材料，该论文于2021年10月获录用待刊。